Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The submission is backed by positive results from the Phase 3 AFFIRM study
The approval was driven by data from the Phase III TULIP-SC trial
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
The summit brought together over 150 doctors, researchers, and practitioners worldwide
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Subscribe To Our Newsletter & Stay Updated